Spontaneous recanalization in deep venous thrombosis: A prospective duplex ultrasound study

International Angiology

Volumn 26, Issue 1, 2007, Pages 53-63

  Puskas A ^a   Balogh, Z ^a   Hadadi, L ^a   Imre, M ^a   Orban E ^a   Kosa K ^a   Brassai, Z ^a   Mousa, S A ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Anticoagulants; Low molecular weight heparins; Risk factors; Thromboembolism; Ultrasonography; Venous thrombosis

Indexed keywords

ACENOCOUMAROL; ORAL CONTRACEPTIVE AGENT; TINZAPARIN; WARFARIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG DOSE TITRATION; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG COMPRESSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PROTECTIVE CLOTHING; RECANALIZATION; RISK FACTOR; SEX DIFFERENCE; TREATMENT RESPONSE;

EID: 34249849951     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Killewich LA, Bedford GR, Beach KW, Strandness DE Jr. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989;9:89-97.
2. Krupski WC, Bass A, Dilley RB, Bernstein EF, Otis SM. Propagation of deep venous thrombosis identified by duplex ultrasonography. J Vasc Surg 1990;12:467-74; discussion 474-5.
3. Eichlisberger R, Frauchiger B, Widmer MT, Widmer LK, Jager K. [Late sequelae of deep venous thrombosis: a 13-year follow-up of 223 patients]. Vasa 1994;23:234-43.
4. Haenen JH, Janssen MC, van Langen H. Duplex ultrasound in the hemodynamic evaluation of the late sequelae of deep venous thrombosis. J Vasc Surg 1998;3:472-8.
5. LeSiege CJ, McKean SC, Persson AV. Importance of valvular incompetence after acute deep venous thrombosis. J Cardiovasc Surg 1992;33:710-4.
6. van Haarst EP, Liasis N, van Ramshorst B, Moll FL. The development of valvular incompetence after deep vein thrombosis: a 7 year follow-up study with duplex scanning. Eur J Vasc Endovasc Surg 1996;12:295-9.
7. Markel A, Meissner M, Manzo RA, Bergelin RO, Strandness DE Jr. Deep venous thrombosis: rate of spontaneous lysis and thrombus extension. Int Angiol 2003;22:376-82.
8. Lensing AW, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous thrombosis with low-molecular-weight heparin: a meta-analysis. Arch Intern Med 1995;155:601-7.
9. Siragusa S, Cosmi B, Piovella F, Hirsch J, Ginsberg GS. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients of acute venous thromboembolism: results of meta-analysis. Am J Med 1996;100: 269-77.
10. Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995;74:606-11.
11. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P et al. A comparison of six weeks with six months of oral anticoagulant ther-apy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995;332:1661-5.
12. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M et al. Warfarin Optimal Duration Italian Trial Investigators. Three months vrrsus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med 2001;345:165-9.
13. Piovella F, Crippa L, Barone M, Vigano D'Angelo S, Serafini S, Galli L et al. Normalization nates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Haematologica 2002;87:515-22.
14. Marder VJ, Soulen RL, Atichartakarn V, Budzynski AZ, Pandekar S, Kim JR et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med 1977;89: 1018-29.
15. Daskalopoulos ME, Daskalopoulou SS, Tzortzis E, Sfiridis P, Nikolaou A, Dimitroulis D et al. Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. Eur J Vasc Endovasc Surg 2005;29:638-50.
16. Anand SS, Wells PS, Hunt D, Brill-Edwards P, Cook D, Ginsberg JS. Does this patient have deep vein thrombosis? JAMA 1998;279:1094-9. Erratum in: JAMA 1998;280: 328. JAMA 1998;279:1614.
17. Polak FJ. Peripheral vascular sonography: a practical guide. Baltimore: Lippincott Williams & Wilkins; 2004.p. 168-227.
18. Masuda EM, Kessler DM, Kistner RL, Eklof B, Sato DT. The natural history of calf vein thrombosis: lysis of thrombi and development of reflux. J Vasc Surg 1998;28:67-73; discussion 73-4.
19. Markel A, Manzo R, Bergelin R, Strandness DE. Valvular reflux after deep vein thrombosis: incidence and time occurrence. J Vasc Surg 1992;15:377-84.
20. Meissner MH, Manzo RA, Bergelin RO, Strandness DE. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993;18:596-605.
21. Johnson BF, Manzo RA, Bergelin MS, Strandness DE. Relationship between changes in the deep venous system and the development of the post-thrombotic syndrome after an acute episode of lower limb deep vein thrombosis. J Vasc Surg 1995;21:307-13.
22. Comerota AJ, Aldridge SC. Thrombolytic therapy for acute deep vein thrombosis. Semin Vasc Surg 1992;5:76-84.
23. Blattler W, Partsch H. Leg compression and ámbulation is better than bed rest for the treatment of acute deep venous thrombosis. Int Angiol 2003;22:393-400.